This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Barbara Driver
Vice President
Contact
BarbaraDriver@westat.comOverview
Barbara Driver is a Vice President for Clinical Research. She oversees multiple clinical research projects conducted in domestic and international settings focusing on infectious disease. Driver leads the Clinical Unit within the Clinical Trials Practice working to ensure Westat operations comply with good clinical practice (GCP) and other applicable requirements.
Education
- MS, Nursing, Lienhard School of Nursing, Pace University
- BS, Health Science/Biology, State University of New York at Cortland
-
Adams et al. respond to “Stop analyzing ‘despair’ deaths together”
American Journal of Epidemiology
January 2023
R.S. Adams, T.L. Spark, C.A. Hoffmire, J.E. Forster, L.A. Brenner
DOILink for: Adams et al. respond to “Stop analyzing ‘despair’ deaths together” -
Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021–2022 season, VISION Network
Journal of Infectious Diseases
January 2023
M.W. Tenforde, Z.A. Weber, M.B. DeSilva, E. Stenehjem, D.-H. Yang, B. Fireman, M. Gaglani, et al.
DOILink for: Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021–2022 season, VISION Network -
Smokeless tobacco use and prevalence of cardiovascular disease among males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1–4
25,
Preventive Medicine Reports
January 2022
G.J. Nahhas, K.M. Cummings, M.J. Halenar, E. Sharma, A.J. Alberg, D. Hatuskami, M. Bansal-Travers, et al.
DOILink for: Smokeless tobacco use and prevalence of cardiovascular disease among males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1–4